Cnb Bank Clovis Oncology, Inc. Transaction History

Cnb Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 03, 2021	SELL	$4.81 - $10.34 $14,670 - $31,537	-3,050 Closed	0 $0
Q2 2020 Jul 14, 2020	BUY	$5.69 - $9.69 $10,811 - $18,411	1,900 Added 165.22%	3,050 $21,000
Q4 2019 Jan 27, 2020	BUY	$3.0 - $16.43 $3,450 - $18,894	1,150 New	1,150 $12,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Cnb Bank, based on Form 13F filings with the SEC.

Stay updated on Cnb Bank with notifications on news.